Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
Last trade$0.00
Day change$0.00 (0.00%)
Day range$0.00 – $0.00
Volume0
Market cap$7M
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$6.93M
Price / earnings
—
Price / book
-0.01×
Price / sales
0×
EV / sales
0.68×
EV / EBITDA
5.3×
Profitability
Earnings per share
-$2.23
Return on assets
-8.25%
Return on equity
30.19%
Dividend yield
0%
Liquidity and leverage
Debt / equity
-3.09×
Current ratio
0.41×
Quick ratio
0.29×
Cash ratio
0.04×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$162.99M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for ACH, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Revenue
$601.78M
$613.23M
$627.78M
Cost of revenue
$340.47M
$349.83M
$349.75M
Gross profit
$261.31M
$263.41M
$278.03M
Selling, general and administrative
$249.46M
$243.56M
$255.23M
Research and development
$0
$0
$0
Total operating expenses
$259.97M
$298.56M
$260.9M
Operating income
$1.33M
-$35.15M
$17.13M
Interest expense
-$37.62M
-$34.54M
-$32.35M
Income before taxes
-$36.82M
-$87.63M
-$16.25M
Income taxes
-$18.86M
$1.44M
-$9.78M
Net income
-$19.7M
-$89.07M
-$6.47M
Net income attributable to common shareholders
-$19.7M
-$89.07M
-$6.47M
EBITDA
$40.25M
$59.78M
$78.87M
Basic earnings per share
-$0.25
-$1.16
-$0.08
Diluted earnings per share
-$0.25
-$1.16
-$0.08
Recent news
Company coverage with links to the original publishers.
Zacks has added three stocks to its Strong Sell list: Accendra Health (ACH), Ardelyx (ARDX), and Draganfly (DPRO). All three companies have experienced significant downward revisions to their earnings estimates over the past 60 days, with ACH seeing a 109.4% downward revision, ARDX a 25% revision, and DPRO a 59.6% revision.
Three companies have been added to the Zacks Rank #5 (Strong Sell) list today due to downward revisions in earnings estimates. AB Volvo faces a 2.3% downward earnings revision, Accendra Health has experienced a significant 109.4% downward revision, and Cameco Corporation saw a 12.2% downward revision over the last 60 days.
Several Chinese companies on Friday announced they would voluntarily delist from the New York Stock Exchange, a move that comes as they faced the prospect of being forcibly removed.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The Securities and Exchange Commission has added popular U.S.-listed Chinese companies to its list of those facing expulsion over lack of audit inspections.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
Jun 30, 2022
$0.1185
Aug 29, 2022
recurring
Apr 26, 2011
$0.0438
Aug 11, 2011
recurring
Sep 23, 2008
$0.19
Jan 8, 2009
recurring
Apr 3, 2008
$0.189
Jul 10, 2008
recurring
Sep 6, 2007
$0.4559
Nov 13, 2007
recurring
Stock splits
Historical share-structure events and their execution dates.